Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Roquefort Thera (ROQ) Share Price

Price 1.70p on 08-05-2025 at 18:00:17
Change 0.05p 3.03%
Buy 1.80p
Sell 1.60p
Buy / Sell ROQ Shares
Last Trade: Sell 150,000.00 at 1.633p
Day's Volume: 1,136,914
Last Close: 1.70p
Open: 1.65p
ISIN: GB00BMDQ2T15
Day's Range 1.65p - 1.70p
52wk Range: 1.50p - 6.25p
Market Capitalisation: £3m
VWAP: 1.674949p
Shares in Issue: 155m

Roquefort Thera (ROQ) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 150,000 1.633p Ordinary
16:05:33 - 08-May-25
Sell* 250,000 1.62p Ordinary
16:05:23 - 08-May-25
Buy* 35,000 1.7473p Ordinary
14:43:59 - 08-May-25
Buy* 100,000 1.75p Ordinary
12:09:36 - 08-May-25
Sell* 100,000 1.69p Ordinary
12:06:05 - 08-May-25
Buy* 165,467 1.7475p Ordinary
11:27:59 - 08-May-25
Sell* 13,830 1.6129p Ordinary
11:01:48 - 08-May-25
Sell* 12,617 1.6129p Ordinary
10:52:15 - 08-May-25
Sell* 10,000 1.6128p Ordinary
10:23:42 - 08-May-25
Buy* 100,000 1.685p Ordinary
08:31:30 - 08-May-25
See more Roquefort Thera trades

Roquefort Thera (ROQ) Share Price History

Time period:
to
Date Open High Low Close Volume
8th May 2025 (Thu) 1.65 1.70 1.65 1.70 1,136,914
7th May 2025 (Wed) 1.70 1.70 1.60 1.65 1,833,857
6th May 2025 (Tue) 1.70 1.70 1.70 1.70 279,369
5th May 2025 (Mon) 1.73 1.73 1.73 1.73 0
2nd May 2025 (Fri) 1.70 1.70 1.70 1.70 573,383
1st May 2025 (Thu) 1.65 1.70 1.65 1.70 692,438
30th Apr 2025 (Wed) 1.85 1.85 1.65 1.65 2,038,158
29th Apr 2025 (Tue) 1.85 1.85 1.85 1.85 694,002
28th Apr 2025 (Mon) 1.85 1.85 1.85 1.85 38,765
25th Apr 2025 (Fri) 1.85 1.85 1.85 1.85 49,381
24th Apr 2025 (Thu) 1.85 1.85 1.85 1.85 186,751
23rd Apr 2025 (Wed) 1.85 1.85 1.85 1.85 66,623
22nd Apr 2025 (Tue) 1.85 1.85 1.85 1.85 508,820
21st Apr 2025 (Mon) 1.85 1.85 1.85 1.85 0
18th Apr 2025 (Fri) 1.85 1.85 1.85 1.85 0
17th Apr 2025 (Thu) 1.85 1.85 1.85 1.85 103,283
16th Apr 2025 (Wed) 1.90 1.90 1.85 1.85 491,365
15th Apr 2025 (Tue) 1.70 1.90 1.70 1.90 938,659
14th Apr 2025 (Mon) 1.80 1.80 1.65 1.70 632,929
11th Apr 2025 (Fri) 1.80 1.90 1.80 1.80 1,334,716
10th Apr 2025 (Thu) 1.80 1.80 1.75 1.80 1,096,497
9th Apr 2025 (Wed) 1.60 1.90 1.60 1.65 3,571,769
See more Roquefort Thera price history

Roquefort Thera (ROQ) Regulatory News

Date Source Headline
30th Apr 2025 7:00 am RNS Annual Report & Financial Statements - 31 Dec 2024
14th Mar 2025 7:00 am RNS Private Placing and Conversion of CLNs
10th Mar 2025 7:30 am RNS Board Changes
10th Mar 2025 7:00 am RNS Proposed Sale of Oncogeni Ltd
4th Mar 2025 7:00 am RNS Update on Sale of Lyramid
4th Feb 2025 10:58 am RNS Director/PDMR Shareholding
3rd Feb 2025 7:00 am RNS Share Purchase Agreement Signed - Sale of Lyramid
2nd Jan 2025 7:00 am RNS Proposed Sale of Midkine Portfolio
4th Dec 2024 4:00 pm RNS Director Share Distribution
7th Nov 2024 7:00 am RNS Conversion of Convertible Loan Notes
See more Roquefort Thera regulatory news

Roquefort Thera (ROQ) Share News

Roquefort Therapeutics CEO resigns, agrees terms for Oncogeni disposal

10th Mar 2025 11:38

(Alliance News) - Roquefort Therapeutics PLC on Monday said it has agreed the terms for the proposed sale of its wholly-owned subsidiary Oncogeni Ltd to UAE-based conglomerate Nations Trust Holding LLC, for up to USD12 million. Read More

SMALL-CAP WINNERS & LOSERS: Roquefort jumps on Oncogeni deal

10th Mar 2025 10:04

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

Roquefort Therapeutics proposes USD10 million subsidiary sale

2nd Jan 2025 14:08

(Alliance News) - Roquefort Therapeutics PLC on Thursday said it has proposed the sale of subsidiary Lyramid Pty Ltd to Pleiades Pharma Ltd for a minimum of USD10 million. Read More

EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart

27th Sep 2024 13:56

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Roquefort Therapeutics says MK cell therapy patent approved in Japan

23rd Sep 2024 17:51

(Alliance News) - Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approved by the Japan Patent Office. Read More

See more Roquefort Thera news
FTSE 100 Latest
Value8,531.61
Change-27.72

Login to your account

Forgot Password?

Not Registered